ArticleAdvances in therapy2023

Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine Tumours.

Jens Otto L Jørgensen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.